Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
An empowerment model of workplace support following disclosure, for people with MS.
Effects of Physical Exercise on Neuroinflammation, Neuroplasticity, Neurodegeneration, and Behavior: What We Can Learn From Animal Models in Clinical Settings.
High-mobility group box 1 in multiple sclerosis.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
Fingolimod for the treatment of relapsing multiple sclerosis.
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis.
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis.
Unusual symptoms and syndromes in multiple sclerosis.
Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine.
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Expression Analysis of CB2-GFP BAC Transgenic Mice.
Deleterious versus protective autoimmunity in multiple sclerosis.
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
ARP2/3 complex is required for directional migration of neural stem cell-derived oligodendrocyte precursors in electric fields.
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex(R)) in people with multiple sclerosis: a new approach.
Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease.
Identification of Risk Factors for Falls in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Magnetic susceptibility anisotropy: Cylindrical symmetry from macroscopically ordered anisotropic molecules and accuracy of MRI measurements using few orientations.
B-cell targeted therapeutics in clinical development.
A novel method for calculating prevalence of multiple sclerosis in Australia.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.

Pages